2019 CAPCaT Awardee and 2019 M2D2 $200K Challenge Winner Respirix - POCTRN
In response to the COVID-19 pandemic, the RADx program was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.
2019 CAPCaT Awardee and 2019 M2D2 $200K Challenge Winner Respirix
Catching up with $200K Challenge Winner
Last April, San Francisco-based startup Respirix was named a first-place winner at the 8th annual M2D2 $200K Challenge. Led by CEO Eric Kriegstein, Respirix won the first Boston Scientific Award for their non-invasive cardiac monitor for congestive heart failure patients. With the 2020 Challenge right around the corner, we checked in with Eric to see what’s happened at Respirix over the last year.